Baylor College of Medicine is recruiting volunteers for a nationwide vaccine trial testing the safety and efficacy of a combination of two potential HIV vaccines and to see if they will stimulate an immune response to HIV.
“The HIV epidemic is still out of control. While HIV medications have improved the survival of people infected with HIV, developing methods to prevent or modify disease are badly needed to change the outlook of this epidemic,” said Dr. Hana El Sahly, assistant professor of molecular virology and microbiology at BCM and principal investigator of the study.
The study is being conducted by the HIV Vaccine Trials Network and Baylor is one of 15 sites across the country participating in the trials. Neither of the vaccines can cause HIV infection.
Researchers are seeking HIV-uninfected (negative) men between 18 and 50 years of age who have sex with men or transgender women who have sex with men.
—
On the Net:
Comments